nimodipine has been researched along with Hearing Loss in 4 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Hearing Loss: A general term for the complete or partial loss of the ability to hear from one or both ears.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Scheller, C | 1 |
Wienke, A | 1 |
Tatagiba, M | 1 |
Gharabaghi, A | 1 |
Ramina, KF | 1 |
Ganslandt, O | 1 |
Bischoff, B | 1 |
Zenk, J | 1 |
Engelhorn, T | 1 |
Matthies, C | 1 |
Westermaier, T | 1 |
Antoniadis, G | 1 |
Pedro, MT | 1 |
Rohde, V | 1 |
von Eckardstein, K | 1 |
Kretschmer, T | 1 |
Kornhuber, M | 1 |
Steighardt, J | 1 |
Richter, M | 1 |
Barker, FG | 1 |
Strauss, C | 1 |
Youssef, AS | 1 |
Downes, AE | 1 |
Kleffner, I | 1 |
Ringelstein, EB | 1 |
Stupp, N | 1 |
Niederstadt, TU | 1 |
Young, P | 1 |
Woolridge, D | 1 |
Stefanelli, M | 1 |
Hoppe, B | 1 |
1 review available for nimodipine and Hearing Loss
Article | Year |
---|---|
Intraoperative neurophysiological monitoring in vestibular schwannoma surgery: advances and clinical implications.
Topics: Action Potentials; Cochlear Nerve; Electromyography; Evoked Potentials, Auditory, Brain Stem; Facial | 2009 |
1 trial available for nimodipine and Hearing Loss
Article | Year |
---|---|
Prophylactic nimodipine treatment and improvement in hearing outcome after vestibular schwannoma surgery: a combined analysis of a randomized, multicenter, Phase III trial and its pilot study.
Topics: Adult; Female; Hearing; Hearing Loss; Hearing Tests; Humans; Male; Middle Aged; Neuroma, Acoustic; N | 2017 |
2 other studies available for nimodipine and Hearing Loss
Article | Year |
---|---|
Neurological picture. Susac's syndrome: effective combination of immunosuppression and antiplatelet treatment.
Topics: Adolescent; Aspirin; Brain Diseases; Corpus Callosum; Female; Glucocorticoids; Hearing Loss; Humans; | 2006 |
Susac syndrome with frontal intermittent rhythmic delta activity (FIRDA).
Topics: Adult; Brain Diseases; Calcium Channel Blockers; Delta Rhythm; Gait Disorders, Neurologic; Hearing L | 2006 |